Cargando…
Evaluation of latent membrane protein 1 and microRNA-155 for the prognostic prediction of diffuse large B cell lymphoma
Diffuse large B cell lymphoma (DLBCL) has previously been demonstrated to contribute to the mortality of lymphoma with various aggressive features. The prognostic role of the biomarkers latent membrane protein (LMP) 1 and microRNA-(miR)-155 in DLBCL remain controversial. The present study primarily...
Autores principales: | Wu, Xue, Wang, Fei, Li, Yuan, Wang, Xiyong, Liu, Ping, Zhang, Haijun, Ge, Zheng, Zhang, Xiaoping, Gao, Chong, Chen, Baoan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5958882/ https://www.ncbi.nlm.nih.gov/pubmed/29844839 http://dx.doi.org/10.3892/ol.2018.8560 |
Ejemplares similares
-
Prognostic Value of MicroRNA-182 in Cancers: A Meta-Analysis
por: Wang, Fei, et al.
Publicado: (2015) -
MicroRNA-155 is a potential molecular marker of natural killer/T-cell lymphoma
por: Zhang, Xudong, et al.
Publicado: (2016) -
MicroRNA-155 Downregulation Promotes Cell Cycle Arrest and Apoptosis in Diffuse Large B-Cell Lymphoma
por: Zhu, Fu-qiang, et al.
Publicado: (2016) -
Prognostic nutritional index and the prognosis of diffuse large b-cell lymphoma: a meta-analysis
por: Luan, Chunyan, et al.
Publicado: (2020) -
MicroRNA-155 expression with Brucella infection in vitro and in vivo and decreased serum levels of MicroRNA-155 in patients with brucellosis
por: Zhang, Xi, et al.
Publicado: (2022)